Home » About us

About us

CORPORATE HIGHLIGHTS

  • Privately-held clinical stage Montreal-based biotechnology company
  • Engaged in the discovery and development of therapeutic mAbs against highly-disease tissue specific novel clinically-relevant targets
  • Currently, having one program in Phase I clinical trial and another IND expected within the next 12 – 15 months
  • Extensive portfolio of highly-specific, novel and clinically-relevant targets using the proprietary STAR technology
  • Exploiting a powerful a proprietary target discovery technology with the potential to expand pipeline
  • Established strategic partnerships to to access mAb generation, humanization, antibody drug conjugates, and CHO production technologies
  • Seasoned management and multi-disciplinary discovery and early-stage development team
  • Unencumbered pipeline with the potential for selected strategic partnerships on therapeutic mAbs